Market Capitalization (Millions $) |
33,086 |
Shares
Outstanding (Millions) |
148 |
Employees |
9,980 |
Revenues (TTM) (Millions $) |
4,775 |
Net Income (TTM) (Millions $) |
1,113 |
Cash Flow (TTM) (Millions $) |
217 |
Capital Exp. (TTM) (Millions $) |
94 |
Resmed Inc
Company Profile: ResMed Inc.
Overview: ResMed Inc. is a global leader in the development, manufacturing, and distribution of innovative products and solutions for sleep apnea and other respiratory conditions. Established in 1989 in Sydney, Australia, ResMed has evolved into a multinational corporation with a presence in over 140 countries.
Products and Solutions: ResMed specializes in designing and producing high-quality medical devices, primarily focused on treating sleep disorders such as obstructive sleep apnea. Key products include:
- Continuous Positive Airway Pressure (CPAP) Machines: Devices that provide air pressure to keep the airways open during sleep. - Masks and Accessories: A range of masks designed for comfort and effectiveness, complemented by essential accessories. - Digital Health Technologies: Cloud-based software solutions that enable healthcare providers to remotely monitor and manage patient conditions.
ResMed's proprietary technology is anchored in advanced ventilation algorithms that utilize sensors and data analytics. This technology customizes treatment plans based on individual patient needs, automatically adjusting air pressure to ensure precise treatment throughout the night, ultimately leading to better sleep and enhanced health outcomes.
Research and Development: The company is devoted to advancing the field of respiratory medicine through substantial investments in research and development. ResMed conducts clinical studies and collaborates with leading healthcare providers and research institutions globally. Additionally, the company works with patient advocacy groups to enhance awareness of sleep disorders, promote patient education, and encourage adherence to treatment protocols.
Headquarters and Global Presence: ResMeds corporate headquarters are located in San Diego, California. It operates additional facilities throughout Australia, Europe, and the Asia-Pacific region, allowing for comprehensive support and distribution of its products internationally.
Recognition and Performance: ResMed has garnered accolades for product innovation, sustainability initiatives, and corporate social responsibility. The company is publicly traded on major stock exchanges, including the New York Stock Exchange (NYSE) and the Australian Securities Exchange (ASX).
Conclusion: Through its commitment to innovation, patient-centric solutions, and global reach, ResMed Inc. continues to impact the field of respiratory health, improving the lives of patients suffering from sleep disorders and contributing to advancements in respiratory medicine.
Company Address: 9001 Spectrum Center Blvd. San Diego 92123 CA
Company Phone Number: 836-5000 Stock Exchange / Ticker: NYSE RMD
|